Basic Information
| LncRNA/CircRNA Name | AC016405.3 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioblastoma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay, Western blot, Microarray |
| Sample | GBM tissue, cell lines (U87MG,U251MG) |
| Expression Pattern | down-regulated |
| Function Description | AC016405.3 was downregulated in 2 GBM cell lines, U87MG and U251MG. |
| Pubmed ID | 30888082 |
| Year | 2019 |
| Title | AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma. |
External Links
| Links for AC016405.3 | GenBank HGNC NONCODE |
| Links for glioblastoma | OMIM COSMIC |